Jiannan Yao
8PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 07, 2025
Hypoxic stimulation of DCLK1 transcription and alternative-promoter switching fuels tumor malignancy in clear cell renal cell carcinoma.Jiannan Yao, Xuying Huang, Qianqian Sun
|May 15, 2024
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration.Wenjing Zhao, Ziwei Liang, Yongshi Yao
|Feb 18, 2022
Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.Ziwei Liang, Enyu Zhang, Ling Duan
|Nov 27, 2021
Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity.Ling Ding, Yuning Yang, Yang Ge
|Aug 31, 2019
Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer.Dongfeng Qu, Nathaniel Weygant, Jiannan Yao
Pageof 2